OBJECTIVES: Upon completion of this activity, the participant should be able to:  (1) 

FACULTY DISCLOSURE: [Speaker Name] has/have no relevant financial relationship(s) with companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

FACULTY DISCLOSURE: [Speaker Name] is/was on (identify relationship and company) the speakers’ bureau for XYZ Device Company.

PLANNER DISCLOSURE: Susan Mathai, MD, is a consultant, independent contractor, patent Beneficiary, site principal investigator and clinical trial, and research study for Natera, Inc, Mount Sinai School of Medicine, CU Innovations, Geven P15, Cumberland, Foresee, Department of Defense, and NIH.  Adam Hayek, DO, is a researcher for Foresee Pharmaceuticals, Co., Ltd, Jansen-Sirukumab, Mesoblast Inc., Regeneron, and Kinevant Sciences GmbHand.  Ginger Tsai-Nguyen, MD, planner has no relevant financial relationship(s) with companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

All relevant financial relationships have been mitigated.

PLANNER DISCLOSURE: The planners have no relevant financial relationship(s) with companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

ACCREDITATION: The A. Webb Roberts Center for Continuing Medical Education of Baylor Scott & White Health is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

DESIGNATION:  The A. Webb Roberts Center for Continuing Medical Education of Baylor Scott & White Health designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

For information, please contact Abby Felty at abby.felty@bswhealth.org